News

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
DexCom, Inc. (NASDAQ: DXCM) has once again demonstrated its formidable position in the continuous glucose monitoring (CGM) ...
After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...
We came across a bullish thesis on DexCom, Inc. (DXCM) on Substack by Na’s Substack. In this article, we will summarize the ...
Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with ...
Glucose tracking is a natural part of Oura’s $75 million investment from Dexcom.
DexCom (NASDAQ:DXCM) stock experienced a significant 16% surge on Friday following its Q1 earnings release and a share buyback announcement. The company’s first-quarter sales reached $1.04 ...
DexCom Inc. closed 39.31% below its 52-week high of $132.26, which the company reached on May 17th.
Ōura, maker of a health-monitoring smart ring, announced that it will use AI to track and analyze two new metabolic health features: meals and glucose.
I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...
The adjusted EBITDA margin outlook also remains around 30%. However, DexCom revised its 2025 adjusted gross profit margin forecast downward to approximately 62%, citing short-term supply-related ...
Oura has today announced that two of the best smart rings on the market, the Oura Ring 3 and Oura Ring 4, now feature support ...